The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Oncology

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
Gastrointestinal

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test

DEC 17, 2019
Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program
Oncology

Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program

NOV 12, 2019
Gut bacteria ‘fingerprint’ predicts radiotherapy side effects
Gastrointestinal

Gut bacteria ‘fingerprint’ predicts radiotherapy side effects

OCT 9, 2019
Bacteria on tumors influences immune response and survival of patients with pancreatic cancer
Oncology

Bacteria on tumors influences immune response and survival of patients with pancreatic cancer

AUG 12, 2019
Precision editing of gut bacteria reduces cancer in mice
Gastrointestinal

Precision editing of gut bacteria reduces cancer in mice

AUG 7, 2019
5-minute Microbiome Science Roundup: April 2019
Editor's Choice

5-minute Microbiome Science Roundup: April 2019

MAY 4, 2019
4D Pharma Clinical Update on MRx0518 Oncology Programmes
Clinical & Manufacturing

4D Pharma Clinical Update on MRx0518 Oncology Programmes

MAY 1, 2019
Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program
Oncology

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

APR 17, 2019
Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients
Oncology

Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients

MAR 27, 2019
Enterome Announces Research Collaboration with Dana-Farber Cancer Institute Focused on New Microbiome-derived Cancer Immunotherapy
Oncology

Enterome Announces Research Collaboration with Dana-Farber Cancer Institute Focused on New Microbiome-derived Cancer Immunotherapy

MAR 22, 2019
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
Finance

Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca

MAR 11, 2019